Giacchi R, Sebastiani M, Lungarotti F
Service de Chirurgie Générale, Hôpitaux Réunis de Pesaro, Italie.
J Chir (Paris). 1988 Jun-Jul;125(6-7):419-23.
The authors present a retrospective study concerning 135 cases of untreated synchronous metastases from colorectal cancer. The median survival is 5.5 months and the natural history is depending on the percentage of liver replacement, on the "performance status" of each patient and on the stage of primary tumors classified according to Dukes. The seric levels of Alkaline Phosphatase and CEA are other useful prognostic factors. The age of patients and systemic chemotherapy (5-Fluorouracil) are not able to influence the evolution of the disease. At last different techniques, both curative and palliative, used in the current treatment of liver metastases from colorectal cancer are discussed and the reported survival improvements reaching with these forms of treatment are compared to the natural history of the disease.
作者们开展了一项关于135例未经治疗的结直肠癌同步转移病例的回顾性研究。中位生存期为5.5个月,其自然病程取决于肝脏替代的比例、每位患者的“体能状态”以及根据Dukes分期法对原发肿瘤的分期。碱性磷酸酶和癌胚抗原的血清水平是其他有用的预后因素。患者的年龄和全身化疗(5-氟尿嘧啶)无法影响疾病的进展。最后讨论了结直肠癌肝转移当前治疗中使用的不同治疗技术,包括根治性和姑息性技术,并将这些治疗方式所实现的生存改善与疾病的自然病程进行了比较。